Compare CDNA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | IRMD |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2007 | 2014 |
| Metric | CDNA | IRMD |
|---|---|---|
| Price | $27.77 | $94.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $28.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 866.7K | 120.6K |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.05 | ★ 0.45 |
| Revenue | $48,324,000.00 | ★ $83,814,000.00 |
| Revenue This Year | $16.01 | $12.38 |
| Revenue Next Year | $11.31 | $11.31 |
| P/E Ratio | $557.00 | ★ $208.60 |
| Revenue Growth | ★ 18.93 | 14.43 |
| 52 Week Low | $10.96 | $55.11 |
| 52 Week High | $28.42 | $107.90 |
| Indicator | CDNA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 71.83 | 55.09 |
| Support Level | $14.59 | $90.62 |
| Resistance Level | N/A | $97.63 |
| Average True Range (ATR) | 1.39 | 3.32 |
| MACD | 0.39 | -0.05 |
| Stochastic Oscillator | 92.28 | 48.71 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.